Spojené štáty - angličtina - NLM (National Library of Medicine)

baxter healthcare corporation - dextrose monohydrate (unii: lx22yl083g) (anhydrous dextrose - unii:5sl0g7r0ok) - dextrose monohydrate 5 g in 100 ml

Spojené štáty - angličtina - NLM (National Library of Medicine)

baxter healthcare corporation - dextrose monohydrate (unii: lx22yl083g) (anhydrous dextrose - unii:5sl0g7r0ok), sodium chloride (unii: 451w47iq8x) (sodium cation - unii:lyr4m0nh37, chloride ion - unii:q32zn48698), sodium lactate (unii: tu7hw0w0qt) (sodium cation - unii:lyr4m0nh37, lactic acid - unii:33x04xa5at), potassium chloride (unii: 660yq98i10) (potassium cation - unii:295o53k152, chloride ion - unii:q32zn48698), calcium chloride (unii: m4i0d6vv5m) (calcium cation - unii:2m83c4r6zb, chloride ion - unii:q32zn48698) - dextrose monohydrate 5 g in 100 ml - potassium chloride in lactated ringer’s and 5% dextrose injection, usp are indicated as a source of water, electrolytes, and calories or as alkalinizing agents. potassium chloride in lactated ringer’s and 5% dextrose injection, usp is contraindicated in:

Spojené štáty - angličtina - NLM (National Library of Medicine)

b. braun medical inc. - dextrose (unii: iy9xdz35w2) (dextrose - unii:iy9xdz35w2) - dextrose 5 g in 100 ml

Spojené štáty - angličtina - NLM (National Library of Medicine)

vedco, inc. - dextrose monohydrate (unii: lx22yl083g) (anhydrous dextrose - unii:5sl0g7r0ok) - dextrose monohydrate 5 g in 100 ml - 5% dextrose injection, usp is indicated as a source of water and calories solutions containing dextrose my be contraindicated in patients with known allergy to corn or corn products

Spojené štáty - angličtina - NLM (National Library of Medicine)

b. braun medical inc. - dextrose (unii: iy9xdz35w2) (dextrose - unii:iy9xdz35w2), sodium chloride (unii: 451w47iq8x) (sodium cation - unii:lyr4m0nh37, chloride ion - unii:q32zn48698), potassium chloride (unii: 660yq98i10) (potassium cation - unii:295o53k152) - dextrose 5 g in 100 ml - these intravenous solutions are indicated for use in adults and pediatric patients as sources of electrolytes, calories and water for hydration. these solutions are contraindicated where the administration of sodium, potassium or chloride could be clinically detrimental. solutions containing dextrose may be contraindicated in patients with hypersensitivity to corn products.

Spojené štáty - angličtina - NLM (National Library of Medicine)

mwi (vetone) - dextrose monohydrate (unii: lx22yl083g) (anhydrous dextrose - unii:5sl0g7r0ok) - dextrose monohydrate 50 g in 100 ml - for use as an aid in the treatment of uncomplicated ketosis in cattle.

Spojené štáty - angličtina - NLM (National Library of Medicine)

baxter healthcare corporation - dextrose hydrous (unii: lx22yl083g) (dextrose - unii:iy9xdz35w2), sodium lactate (unii: tu7hw0w0qt) (sodium lactate - unii:tu7hw0w0qt), potassium chloride (unii: 660yq98i10) (potassium chloride - unii:660yq98i10), sodium chloride (unii: 451w47iq8x) (sodium chloride - unii:451w47iq8x), potassium phosphate, monobasic (unii: 4j9fj0hl51) (potassium phosphate, monobasic - unii:4j9fj0hl51) - injection, solution - 5 g in 100 ml - 5% dextrose and electrolyte no. 75 injection (multiple electrolytes and dextrose injection, type 3, usp) is indicated as a source of water, electrolytes and calories or as an alkalinizing agent. solutions containing dextrose may be contraindicated in patients with known allergy to corn or corn products.

Spojené štáty - angličtina - NLM (National Library of Medicine)

b. braun medical inc. - dextrose (unii: iy9xdz35w2) (dextrose - unii:iy9xdz35w2), potassium chloride (unii: 660yq98i10) (potassium cation - unii:295o53k152) - dextrose 5 g in 100 ml - potassium chloride in dextrose injection is indicated as a source of electrolytes, calories, and water for hydration.  potassium chloride in dextrose injection is contraindicated in patients with: - known hypersensitivity to potassium chloride and/or dextrose [see warnings and precautions 5.1)] - clinically significant hyperkalemia [see warnings and precautions (5.2)] -   clinically significant hyperglycemia [see warnings and precautions (5.3)] risk summary appropriate administration of potassium chloride in dextrose injection during pregnancy is not expected to cause adverse developmental outcomes, including congenital malformations. animal reproduction studies have not been conducted with potassium chloride in dextrose injection. the estimated background risk of major birth defects and miscarriage for the indicated population is unknown. all pregnancies have a background risk of birth defect, loss, or other adverse outcomes. in the u.s. general population, the estimated background risk of major birth defec

Spojené štáty - angličtina - NLM (National Library of Medicine)

citra labs llc - dextrose monohydrate (unii: lx22yl083g) (anhydrous dextrose - unii:5sl0g7r0ok), anhydrous citric acid (unii: xf417d3psl) (anhydrous citric acid - unii:xf417d3psl), trisodium citrate dihydrate (unii: b22547b95k) (anhydrous citric acid - unii:xf417d3psl) - dextrose monohydrate 0.245 g in 10 ml - anticoagulant citrate dextrose solution, solution a, u.s.p. (acd-a), is intended for use as an anticoagulant in the extracorporeal blood processing with autologous prp systems in production of platelet rich plasma (prp). refer to the manufacturer's operator's manual of the autologous prp system for the directions for use. not for direct intravenous infusion

Spojené štáty - angličtina - NLM (National Library of Medicine)

general injectables & vaccines, inc - dextrose monohydrate (unii: lx22yl083g) (anhydrous dextrose - unii:5sl0g7r0ok) - dextrose monohydrate 250 mg in 1 ml - 25% dextrose injection is indicated in the treatment of acute symptomatic episodes of hypoglycemia in the neonate or older infant to restore depressed blood glucose levels and control symptoms. other drugs, such as epinephrine and glucagon, should be considered in patients unresponsive or intolerant to dextrose (glucose). oral feeding of dextrose may be necessary in infants with frequently recurring hypoglycemic episodes or to prevent recurrences due to hyperinsulinemia. 25% dextrose injection also provides a minimal source of carbohydrate calories. a concentrated dextrose solution should not be used when intracranial or intraspinal hemorrhage is present.